Mitochondrial electron transport chain cofactor. Studied for cardiovascular disease, statin-associated myopathy, heart failure, and mitochondrial dysfunction. Levels decline with age and statin use.
33 hours; once-daily dosing with fat-containing meal
SKUs
2
Evidence
Moderate Evidence
Coenzyme Q10 (CoQ10) is a compound that the body produces naturally and that plays a central role in the mitochondrial energy production chain. It also functions as an antioxidant. CoQ10 levels decline with age and with use of certain medications, particularly statins. It has been studied for cardiovascular health, heart failure, mitochondrial disease, and as a general supplement for energy and antioxidant support.
Heart Failure Research
The Q-SYMBIO trial — one of the larger CoQ10 trials — studied 420 patients with moderate-to-severe heart failure. The CoQ10 group had significantly lower rates of major adverse cardiovascular events and cardiovascular mortality compared to placebo at two years. This was a meaningful finding in a difficult-to-treat condition.
Statin-Associated Muscle Symptoms
Statins reduce the body's production of CoQ10 alongside cholesterol. Supplementation has been studied as a way to reduce statin-associated muscle pain and fatigue. Results from trials are mixed — some show benefit, others show no significant effect compared to placebo.
Mitochondrial Disease
For people with certain mitochondrial disorders, CoQ10 supplementation is often part of standard supportive management. Research in these populations shows improvements in energy levels and mitochondrial function markers, though CoQ10 is not a cure for these conditions.
Blood Pressure Research
Meta-analyses of small trials have suggested CoQ10 supplementation may modestly reduce systolic blood pressure. Effect sizes are modest but consistent across studies, and the safety profile makes it a low-risk addition to research protocols.
Q-SYMBIO trial showed reduction in major cardiovascular events and cardiovascular mortality in heart failure patients.
Meta-analyses suggest modest reductions in blood pressure with supplementation.
Mixed evidence for reducing statin-associated muscle symptoms.
Supportive evidence for use in mitochondrial disorders.
Well-tolerated with a long safety record across many studies.
The Q-SYMBIO trial findings have not been replicated in a similarly large trial, which means the heart failure findings, while interesting, need confirmation. For most other applications, the evidence is from small trials and meta-analyses of heterogeneous studies. Oral bioavailability of CoQ10 is relatively low and varies significantly between formulations. Ubiquinol forms may have higher bioavailability than ubiquinone forms.
Every cell in your body uses a chain of reactions inside mitochondria to convert food into usable energy. CoQ10 is an essential part of that chain — it acts as a shuttle, carrying electrons between the protein complexes that drive energy production. Without enough CoQ10, this process becomes less efficient. CoQ10 also acts as an antioxidant, capturing harmful reactive oxygen species produced as a byproduct of energy metabolism before they can damage cell structures. As you age, your body naturally produces less CoQ10. Statins, which block a pathway shared with CoQ10 synthesis, can accelerate this decline. Supplementing CoQ10 aims to restore levels that may have dropped below the amount needed for optimal mitochondrial function.
CoQ10 has an excellent safety record across decades of research and supplementation use. Side effects are uncommon and mild — occasional GI symptoms. It is a common over-the-counter supplement. It may have mild blood pressure lowering effects, which is worth noting for people already on blood pressure medications. It can potentially interact with warfarin at high doses. It is not FDA-approved as a drug but is widely available as a supplement.
Moderate Evidence
This compound has been studied in Phase 1 or Phase 2 human trials. Evidence is encouraging but more large-scale trials are needed.
Published Research Ranges
100–400mg/day typical research range; higher doses (600–1200mg/day) in specific conditions
Research Context Only: These are ranges reported in published scientific studies for educational reference. They are not dosing recommendations. This is not medical advice. Always consult a qualified healthcare professional.
Sources listed here are from the platform research library. All links open the original publication. No citations are generated by AI.
Coenzyme Q10 in Heart Failure Mortality and Morbidity (Q-SYMBIO): RCT
Introducing the 'Drucebo' effect in statin therapy: a systematic review of studies comparing reported rates of statin-associated muscle symptoms, under blinded and open-label conditions
Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: A possible approach to SARS-CoV-2 'long-haulers'?
Research Education Only: This profile is for educational purposes only. All information is sourced from published scientific literature. This is not medical advice. Not for human consumption. Consult qualified medical professionals for any health decisions.
We use cookies to enhance your research experience and analyze platform usage. By continuing, you agree to our Cookie Policy.